A case which concluded the experiment or research of generic drugs was not an infringement of a patent: the Judgment of April 16, 1999, Supreme Court of Japan
Practices:Patents
Category:Cases
| Authors | KANDA, Takeshi |
|---|---|
| Practice Areas | Patents |
| Date of publication | November 6th, 2007 |
| Publication carrying this article | Business Law Case Study 300, Volume on Corporate Transactions and Intellectual Property |
| Publisher | KINZAI INSTITUTE FOR FINANCIAL AFFAIRS |
Summary
Other works on Patents
-
Publications Patents Laws
2026- Study Question by Standing Committee on Biotechnology “Patentability of Microbiomes”
YAMAMOTO, Osamu
-
Publications Intellectual Property、Patents Cases
Japan at a crossroads: pharmaceutical patents and generic entry
YAMAMOTO, Osamu
-
Publications Intellectual Property、Patents Laws
The Fifth Requirement of the Doctrine of Equivalents – Intentional Exclusion
FUKAI, Toshiyuki
-
Publications Intellectual Property、Patents、Designs、Trademarks、Copyright Law、Unfair Competition Laws
Basics of Measures against Counterfeit Goods-Legal Grounds and Concrete Methods for Injunctive Relief
FUKAI, Toshiyuki
-
Publications Intellectual Property、Patents Laws
Official Filing Fees for Patent Infringement Litigation
FUKAI, Toshiyuki
Telephone
+81(3)3270-6641

